MIR17HG Gene Feingold Syndrome Type 2 Genetic Test
Test Name: MIR17HG Gene Feingold syndrome type 2 Genetic Test
Components: DNA Labs UAE
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MIR17HG Gene Feingold syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MIR17HG Gene Feingold syndrome type 2 NGS Genetic DNA Test gene MIR17HG
Test Details:
The MIR17HG gene is a gene located on chromosome 13 that encodes for a microRNA. MicroRNAs are small RNA molecules that play a role in regulating gene expression.
Feingold syndrome type 2 is a rare genetic disorder characterized by various physical abnormalities, such as hand and foot abnormalities, microcephaly (small head size), and gastrointestinal and cardiac defects. It is caused by mutations in the MIR17HG gene.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for mutations or variants. In the case of Feingold syndrome type 2, NGS genetic testing can be used to identify mutations in the MIR17HG gene.
The test involves obtaining a DNA sample, usually through a blood sample, and sequencing the DNA using NGS technology. The sequencing data is then analyzed to identify any mutations or variants in the MIR17HG gene that may be causing Feingold syndrome type 2.
NGS genetic testing for Feingold syndrome type 2 can help in confirming a diagnosis, guiding treatment decisions, and providing genetic counseling for affected individuals and their families.
Test Name | MIR17HG Gene Feingold syndrome type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MIR17HG Gene Feingold syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MIR17HG Gene Feingold syndrome type 2 NGS Genetic DNA Test gene MIR17HG |
Test Details |
The MIR17HG gene is a gene located on chromosome 13 that encodes for a microRNA. MicroRNAs are small RNA molecules that play a role in regulating gene expression. Feingold syndrome type 2 is a rare genetic disorder characterized by various physical abnormalities, such as hand and foot abnormalities, microcephaly (small head size), and gastrointestinal and cardiac defects. It is caused by mutations in the MIR17HG gene. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for mutations or variants. In the case of Feingold syndrome type 2, NGS genetic testing can be used to identify mutations in the MIR17HG gene. The test involves obtaining a DNA sample, usually through a blood sample, and sequencing the DNA using NGS technology. The sequencing data is then analyzed to identify any mutations or variants in the MIR17HG gene that may be causing Feingold syndrome type 2. NGS genetic testing for Feingold syndrome type 2 can help in confirming a diagnosis, guiding treatment decisions, and providing genetic counseling for affected individuals and their families. |